Moleculin Biotech Inc

MBRX Financials — Income Statement, Margins & Balance Sheet

Revenue, net income, margins, cash and debt for MBRX, built from reported filings and live market data.

$6.83-4.34% todayUSD · live quote
★ ZCoreAI PREMIUM7 days free

Unlock Full MBRX Analysis

Explore Z-Score, Smart Money signals, all timeframes and Premium indicators for MBRX.

✓Z-Score signals
✓Smart Money flow
✓All timeframes
✓Premium indicators
Start 7-Day Free Trial →

7-day free trial. No commitment during the trial.

MBRX Income Statement (TTM)

$0
Trailing twelve-month revenue reported by MBRX.
Net income (TTM)
-$11.42M
EPS (TTM)
$-429.80
Gross margin
—
Operating margin
—
Net margin
—
Revenue growth
—

MBRX Revenue vs Net Income by Reported Period

Light bars are revenue, solid bars are net income. The gap between them is the cost of running the business — when it narrows, margins are expanding.

A reported revenue series for MBRX is not available from public filings right now.

MBRX Financial Results by Period

The last 12 reported periods for MBRX, most recent first.

PeriodRevenueNet incomeNet marginEPS
Q3 2026$0-$6.49M—$9.00
Q2 2026$0-$7.63M—$-28.00
Q1 2026$0-$12.85M—$-70.80
Q4 2025$0$15.55M——
Q3 2025$0-$35.04M—$-340.00
Q2 2025$0-$7.64M—$-573.60
Q1 2025$0-$6.44M—$-316.00
Q4 2024$0-$1.88M——
Q3 2024$0-$10.59M—$-945.00
Q2 2024$0-$4.32M—$-1185.00
Q1 2024$0-$4.97M—$-1305.00
Q4 2023$0———

MBRX Balance Sheet & Cash Generation

Cash, debt, share count and free cash flow — the inputs that decide whether MBRX can fund growth without diluting shareholders.

Cash
$7.26M
Total debt
$0
Net cash / (debt)
$7.26M
Shares outstanding
0.00B
Free cash flow
-$22.73M
FCF yield
-317.0%
Market cap
$7.17M
Price / sales
—

Financials vs Valuation & Market Positioning

The statements tell you what the business earns; the multiples and Z-Score tell you what the market is currently charging for it.

Trailing P/E
—
Forward P/E
—
EPS growth
—
Revenue growth
—

Z-Score readings for MBRX are not available right now.

How This MBRX Financial Data Is Built

Revenue, net income and EPS come from MBRX's reported filings through live ZCoreAI market endpoints. Trailing twelve-month figures sum the last four reported quarters, and net margin per period is net income divided by revenue for that same period. Gross and operating margins are taken from the reported profitability block.

Cash, debt and share count come from the latest published balance sheet; where a figure is absent, free cash flow is approximated from reported net income and shares are derived from market cap divided by price. Price to sales, FCF yield and the multiples use the live quote, so they update on every page load. Nothing here is investment advice.

MBRX Financials FAQ

How much revenue does MBRX generate?

Trailing revenue for MBRX is not available from reported filings right now.

Is MBRX profitable?

Profitability for MBRX cannot be computed from currently reported figures.

Does MBRX have too much debt?

MBRX carries $0 of total debt against $7.26M of cash, a net cash position of $7.26M. Compare that against free cash flow of -$22.73M to judge how quickly it could be repaid.

What is MBRX's free cash flow?

MBRX generated negative free cash flow of -$22.73M, a -317.0% yield on the current market cap. Free cash flow is what funds buybacks, dividends and debt repayment.

Where does ZCoreAI get MBRX financial data?

Revenue, net income, EPS, margins and balance sheet items come from live ZCoreAI market endpoints sourced from company filings, refreshed on every page load.

MBRX earnings

Quarterly EPS history, revenue trend and growth for MBRX.

MBRX P/E ratio

Trailing and forward multiples, PEG and earnings yield for MBRX.

MBRX forecast

DCF fair value, price prediction and signal targets for MBRX.

MBRX overview

Live chart, fundamentals and valuation context for MBRX.

Research tools we use

  • Koyfin

    Financial data, screening and market research dashboards.

  • Stock Rover

    Stock screening and fundamental research for dividend and value investors.

Data refreshed from live ZCoreAI market endpoints. Informational only — not investment advice.